Advanced Health Intelligence Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Advanced Health Intelligence şirketinin kazançları yıllık ortalama -25.2% oranında azalırken, Healthcare Services sektörünün kazançları yıllık 13% oranında artan oldu. Gelirler yıllık ortalama 9.1% oranında artan oldu.

Anahtar bilgiler

-25.2%

Kazanç büyüme oranı

-10.7%

EPS büyüme oranı

Healthcare Services Sektör Büyümesi	42.6%
Gelir büyüme oranı	9.1%
Özkaynak getirisi	n/a
Net Marj	1,800.9%
Son Kazanç Güncellemesi	31 Dec 2023

Yakın geçmiş performans güncellemeleri

Recent updates

Gelir ve Gider Dağılımı

Advanced Health Intelligence nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

ASX:AHI Gelir, gider ve kazançlar (AUD Millions )
Tarih	Gelir	Kazançlar	G+A Giderleri
31 Dec 23	-1	-17	8
30 Sep 23	0	-15	7
30 Jun 23	1	-13	6
31 Mar 23	2	-11	7
31 Dec 22	2	-10	8
30 Sep 22	1	-15	8
30 Jun 22	0	-20	8
31 Mar 22	0	-22	6
31 Dec 21	0	-23	4
30 Sep 21	0	-19	4
30 Jun 21	1	-14	3
31 Mar 21	1	-11	3
31 Dec 20	1	-8	3
30 Sep 20	1	-7	3
30 Jun 20	0	-5	3
31 Mar 20	0	-5	2
31 Dec 19	0	-5	2
30 Sep 19	0	-5	2
30 Jun 19	0	-4	2
31 Mar 19	0	-4	2
31 Dec 18	0	-4	2
30 Sep 18	1	-9	2
30 Jun 18	2	-14	2
31 Mar 18	2	-14	2
31 Dec 17	2	-13	2
30 Sep 17	1	-8	2
30 Jun 17	0	-2	1
31 Mar 17	0	-2	1
31 Dec 16	0	-2	1
30 Sep 16	0	-2	1
30 Jun 16	0	-2	1
30 Jun 15	0	-1	1

Kaliteli Kazançlar: AHI şu anda kârlı değil.

Büyüyen Kar Marjı: AHI şu anda kârlı değil.

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: AHI kârlı değildir ve zararlar son 5 yılda yılda 25.2% oranında artmıştır.

Büyüme Hızlandırma: AHI 'un son bir yıldaki kazanç büyümesinin 5 yıllık ortalamasıyla karşılaştırılması mümkün değil çünkü şu anda kârlı değil

Kazançlar vs. Sektör: AHI kârlı olmadığından, geçmiş yıl kazanç büyümesinin Healthcare Services sektörüyle ( 13.3% ) karşılaştırılması zorlaşıyor.

Özkaynak Getirisi

Yüksek ROE: AHI 'un yükümlülükleri varlıklarından fazla olduğundan Özsermaye Getirisi'ni hesaplamak zordur.

Advanced Health Intelligence Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Anahtar bilgiler

Yakın geçmiş performans güncellemeleri

Full year 2023 earnings released: AU$0.072 loss per share (vs AU$0.13 loss in FY 2022)

First half 2023 earnings released: AU$0.024 loss per share (vs AU$0.10 loss in 1H 2022)

Full year 2022 earnings released: AU$0.15 loss per share (vs AU$0.11 loss in FY 2021)

Full year 2022 earnings released: AU$0.13 loss per share (vs AU$0.11 loss in FY 2021)

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Full year 2021 earnings released: AU$0.11 loss per share (vs AU$0.052 loss in FY 2020)

Recent updates

Advanced Health Intelligence Ltd, Annual General Meeting, Nov 29, 2024

Advanced Health Intelligence Ltd(NasdaqCM:AHI) dropped from NASDAQ Composite Index

Advanced Health Intelligence Ltd has filed a Follow-on Equity Offering in the amount of AUD 1.9575 million.

Advanced Health Intelligence Ltd. has completed a Follow-on Equity Offering in the amount of AUD 0.2 million.

Advanced Health Intelligence Ltd to Launch Medically Approved Mobile Phone-Based Atrial Fibrillation Assessment

Advanced Health Intelligence Ltd. has filed a Follow-on Equity Offering in the amount of AUD 2.1995 million.

Advanced Health Intelligence Ltd. has filed a Follow-on Equity Offering in the amount of AUD 2.1995 million.

Advanced Health Intelligence Ltd. announced delayed 20-F filing

Advanced Health Intelligence Ltd., Annual General Meeting, Nov 17, 2023

Advanced Health Intelligence Ltd. announced that it has received AUD 1.5 million in funding

Full year 2023 earnings released: AU$0.072 loss per share (vs AU$0.13 loss in FY 2022)

New minor risk - Financial data availability

Advanced Health Intelligence Ltd. has completed a Follow-on Equity Offering in the amount of AUD 5 million.

New major risk - Share price stability

First half 2023 earnings released: AU$0.024 loss per share (vs AU$0.10 loss in 1H 2022)

Forecast breakeven date pushed back to 2025

High number of new directors

Advanced Health Intelligence Ltd. Announces Board Changes

Advanced Human Imaging Limited (ASX:AHI) completed the acquisition of WellteQ Digital Health Inc. (CNSX:WTEQ).

Advanced Human Imaging Appoints Dr. Peter Vaughan as Non-Executive Director

Advanced Human Imaging Limited announced delayed 20-F filing

Advanced Human Imaging Limited, Annual General Meeting, Nov 29, 2022

Full year 2022 earnings released: AU$0.15 loss per share (vs AU$0.11 loss in FY 2021)

Forecast breakeven date pushed back to 2025

Full year 2022 earnings released: AU$0.13 loss per share (vs AU$0.11 loss in FY 2021)

Advanced Human Imaging Limited (ASX:AHI) executed a non-binding letter of intent to acquire WellteQ Digital Health Inc. (CNSX:WTEQ) for AUD 4.3 million.

Advanced Human Imaging Ltd Appoints Peter Goldstein as Non-Executive Director

Advanced Human Imaging Limited to Be Deleted from Other OTC

Advanced Human Imaging Limited Announces Resignation of Edward Greissing Jr as Director

Does Advanced Human Imaging (ASX:AHI) Have A Healthy Balance Sheet?

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Forecast to breakeven in 2023

Advanced Human Imaging Limited Appoints Dr. Katherine Iscoe as Director

Advanced Human Imaging Limited Announces Executive Changes

Full year 2021 earnings released: AU$0.11 loss per share (vs AU$0.052 loss in FY 2020)

Advanced Human Imaging Limited Announces the Submission of the Health Cube App into the Top 10 China App Stores with Tinjoy Biotech Limited

No independent directors

No independent directors

No independent directors

No independent directors

No independent directors

Full year 2021 earnings released: AU$0.11 loss per share (vs AU$0.052 loss in FY 2020)

Advanced Human Imaging Limited Announces Derma AI Embedded in the AHI DermaScan Receives CE Mark Clearance in the European Union for the Dermatology AI Component in CompleteScan

Advanced Human Imaging's DermaScan AI Receives Medical Device Approval 27 EU Countries (CE Mark)

Advanced Human Imaging Limited to Launch BodyScan in Original Fit Factory's Fitness App Truconnect to Audience of 150+ Million

Advanced Human Imaging (ASX:AHI) Has Debt But No Earnings; Should You Worry?

New 90-day high: AU$2.17

First half 2021 earnings released: AU$0.046 loss per share (vs AU$0.029 loss in 1H 2020)

What We Learned About MyFiziq's (ASX:MYQ) CEO Compensation

MyFiziq Limited to Appoint New US Board Members in Readiness for Nasdaq

MyFiziq Names William Bradford as New Global Chief Business Officer in USA

New 90-day high: AU$1.35

How Many MyFiziq Limited (ASX:MYQ) Shares Have Insiders Sold, In The Last Year?

MyFiziq Signs Marketing and Expansion Agreement with Bearn

MyFiziq Limited Announces Management Changes

Myfiziq Limited Releases Applications with Biomorphik Pty Ltd App with the Myfiziq Technology

Do Insiders Own Lots Of Shares In MyFiziq Limited (ASX:MYQ)?

MyFiziq Limited Completes Definitive Agreements with MVMNT Inc

MyFiziq Limited announced that it expects to receive AUD 5 million in funding

MyFiziq Limited Signs Binding Term Sheet with Jayex Healthcare Limited

Myfiziq Limited Signs Agreement with Nexus-Vita with USD 3.5 Million Guarantee

MyFiziq Limited Auditor Raises 'Going Concern' Doubt

Full year earnings released - AU$0.052 loss per share

New 90-day high: AU$1.32

MyFiziq Limited Signs Definitive Agreements with Biomorphik to Accelerate A November 2020 Release

New 90-day high - AU$0.61

Full year earnings released - AU$0.052 loss per share

New 90-day high - AU$0.32

Gelir ve Gider Dağılımı